title: Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer.
authors.affiliation: National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.
authors.forename: J L
authors.initials: JL
authors.lastname: Mulshine
authors.forename: I
authors.initials: I
authors.lastname: Avis
authors.forename: A M
authors.initials: AM
authors.lastname: Treston
authors.forename: C
authors.initials: C
authors.lastname: Mobley
authors.forename: P
authors.initials: P
authors.lastname: Kaspryzyk
authors.forename: J A
authors.initials: JA
authors.lastname: Carrasquillo
authors.forename: S M
authors.initials: SM
authors.lastname: Larson
authors.forename: Y
authors.initials: Y
authors.lastname: Nakanishi
authors.forename: B
authors.initials: B
authors.lastname: Merchant
authors.forename: J D
authors.initials: JD
authors.lastname: Minna
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000917:Antibody Formation; D001839:Bombesin / Q000276:immunology*; D018288:Carcinoma, Small Cell / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D019886:Gastrin-Releasing Peptide; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*; D010455:Peptides / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D010455:Peptides; D019886:Gastrin-Releasing Peptide; D001839:Bombesin